Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, India.
Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, India.
SLAS Technol. 2023 Jun;28(3):102-126. doi: 10.1016/j.slast.2023.03.006. Epub 2023 Apr 5.
Tissue-engineered nerve guidance conduits (NGCs) are a viable clinical alternative to autografts and allografts and have been widely used to treat peripheral nerve injuries (PNIs). Although these NGCs are successful to some extent, they cannot aid in native regeneration by improving native-equivalent neural innervation or regrowth. Further, NGCs exhibit longer recovery period and high cost limiting their clinical applications. Additive manufacturing (AM) could be an alternative to the existing drawbacks of the conventional NGCs fabrication methods. The emergence of the AM technique has offered ease for developing personalized three-dimensional (3D) neural constructs with intricate features and higher accuracy on a larger scale, replicating the native feature of nerve tissue. This review introduces the structural organization of peripheral nerves, the classification of PNI, and limitations in clinical and conventional nerve scaffold fabrication strategies. The principles and advantages of AM-based techniques, including the combinatorial approaches utilized for manufacturing 3D nerve conduits, are briefly summarized. This review also outlines the crucial parameters, such as the choice of printable biomaterials, 3D microstructural design/model, conductivity, permeability, degradation, mechanical property, and sterilization required to fabricate large-scale additive-manufactured NGCs successfully. Finally, the challenges and future directions toward fabricating the 3D-printed/bioprinted NGCs for clinical translation are also discussed.
组织工程神经导管(NGCs)是自体移植物和同种异体移植物的可行临床替代物,已被广泛用于治疗周围神经损伤(PNI)。尽管这些 NGC 在某种程度上是成功的,但它们不能通过改善原生等效的神经支配或再生来帮助原生再生。此外,NGCs 表现出较长的恢复时间和高成本,限制了它们的临床应用。增材制造(AM)可能是现有传统 NGC 制造方法缺点的替代方法。AM 技术的出现为开发具有复杂特征和更高精度的个性化三维(3D)神经结构提供了便利,可以在更大的规模上复制神经组织的固有特征。本综述介绍了周围神经的结构组织、PNI 的分类以及临床和传统神经支架制造策略的局限性。简要总结了基于 AM 的技术的原理和优势,包括用于制造 3D 神经导管的组合方法。本文还概述了成功制造大尺寸增材制造 NGC 所需的关键参数,如可打印生物材料的选择、3D 微观结构设计/模型、导电性、渗透性、降解、机械性能和灭菌。最后,还讨论了制造用于临床转化的 3D 打印/生物打印 NGC 面临的挑战和未来方向。